Holen Sie sich die Stockscreener-App
2.40
4.00%
-0.10
Finanzdaten der Arca Biopharma Inc-Aktie (ABIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
56.10%
2.482
|
1.59 | 1.937 | 1.973 | 1.796 |
| Depreciation and Amortization |
0.00%
0.003
|
0.003 | 0.004 | 0.004 | 0.004 |
| Operating Income/Loss |
56.10%
-2.482
|
-1.59 | -1.937 | -1.973 | -1.796 |
| Income/Loss From Continuing Operations Before Tax |
84.48%
-2.009
|
-1.089 | -1.424 | -1.48 | -1.346 |
| Income/Loss From Continuing Operations After Tax |
84.48%
-2.009
|
-1.089 | -1.424 | -1.48 | -1.346 |
|
Net Income/Loss
|
84.48%
-2.009
|
-1.089 | -1.424 | -1.48 | -1.346 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
252.80K%
14.50
|
0.00573 | 14.41 | 14.41 | 14.41 |
| Diluted Average Shares |
252.80K%
14.50
|
0.00573 | 14.41 | 14.41 | 14.41 |
| Basic Earnings Per Share |
75.00%
-0.14
|
-0.08 | -0.10 | -0.10 | -0.09 |
| Diluted Earnings Per Share |
75.00%
-0.14
|
-0.08 | -0.10 | -0.10 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.54%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):